1-[4-(hydroxymethyl)phenyl]guanidine
Star0
Identification
- Generic Name
- 1-[4-(hydroxymethyl)phenyl]guanidine
- DrugBank Accession Number
- DB06900
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 165.1924
Monoisotopic: 165.090211989 - Chemical Formula
- C8H11N3O
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UProstasin Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as benzyl alcohols. These are organic compounds containing the phenylmethanol substructure.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Benzene and substituted derivatives
- Sub Class
- Benzyl alcohols
- Direct Parent
- Benzyl alcohols
- Alternative Parents
- Guanidines / Propargyl-type 1,3-dipolar organic compounds / Primary alcohols / Organopnictogen compounds / Hydrocarbon derivatives / Aromatic alcohols
- Substituents
- Alcohol / Aromatic alcohol / Aromatic homomonocyclic compound / Benzyl alcohol / Guanidine / Hydrocarbon derivative / Organic 1,3-dipolar compound / Organic nitrogen compound / Organic oxygen compound / Organonitrogen compound
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- JAFHTIHHRCEJDS-UHFFFAOYSA-N
- InChI
- InChI=1S/C8H11N3O/c9-8(10)11-7-3-1-6(5-12)2-4-7/h1-4,12H,5H2,(H4,9,10,11)
- IUPAC Name
- N-[4-(hydroxymethyl)phenyl]guanidine
- SMILES
- NC(=N)NC1=CC=C(CO)C=C1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 17975425
- PubChem Substance
- 99443371
- ChemSpider
- 16465530
- ZINC
- ZINC000015555321
- PDBe Ligand
- 1JZ
- PDB Entries
- 3fvf
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.858 mg/mL ALOGPS logP 0.3 ALOGPS logP 0.18 Chemaxon logS -2.3 ALOGPS pKa (Strongest Acidic) 15.1 Chemaxon pKa (Strongest Basic) 10.64 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 82.13 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 59.01 m3·mol-1 Chemaxon Polarizability 17.56 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9154 Blood Brain Barrier + 0.8731 Caco-2 permeable - 0.5407 P-glycoprotein substrate Non-substrate 0.7699 P-glycoprotein inhibitor I Non-inhibitor 0.9764 P-glycoprotein inhibitor II Non-inhibitor 0.7623 Renal organic cation transporter Non-inhibitor 0.6949 CYP450 2C9 substrate Non-substrate 0.7806 CYP450 2D6 substrate Non-substrate 0.6949 CYP450 3A4 substrate Non-substrate 0.8464 CYP450 1A2 substrate Non-inhibitor 0.8072 CYP450 2C9 inhibitor Non-inhibitor 0.8706 CYP450 2D6 inhibitor Non-inhibitor 0.8775 CYP450 2C19 inhibitor Non-inhibitor 0.9044 CYP450 3A4 inhibitor Non-inhibitor 0.8793 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9588 Ames test AMES toxic 0.5728 Carcinogenicity Non-carcinogens 0.6691 Biodegradation Not ready biodegradable 0.8275 Rat acute toxicity 2.2760 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9194 hERG inhibition (predictor II) Non-inhibitor 0.9705
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-00di-2900000000-3bb131118f34de0aed71 Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-014i-0900000000-c93a26d12d6253e89dd9 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-00dl-8900000000-3b3d21015cbfe5754b54 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0a4i-0900000000-571d00bc05d8de0ba2db Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-0006-9000000000-df219d38b72c8a3cb9a1 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0006-9300000000-c514a34ce1a961373f7a Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0a6r-8900000000-001de497e1e5b82ccb64 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 140.54709 predictedDeepCCS 1.0 (2019) [M+H]+ 143.9599 predictedDeepCCS 1.0 (2019) [M+Na]+ 153.45143 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsProstasin
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Serine-type peptidase activity
- Specific Function
- Possesses a trypsin-like cleavage specificity with a preference for poly-basic substrates. Stimulates epithelial sodium channel (ENaC) activity through activating cleavage of the gamma subunits (SC...
- Gene Name
- PRSS8
- Uniprot ID
- Q16651
- Uniprot Name
- Prostasin
- Molecular Weight
- 36431.12 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:17 / Updated at June 12, 2020 16:52